文献速递牙周病

微生物检测与牙周基础治疗后全身抗生素处方的交叉问卷研究

A questionnaire-based crossover study on the association of microbiological testing with prescription of systemic antibiotics following initial periodontal therapy.
PubMed 文献 · J Clin Periodontol · 2021-03-30

微生物检测与处方无关,但医生经验和牙周炎分期等因素与处方相关。

要点

  • 微生物检测信息未显著影响牙周基础治疗后全身抗生素处方(p=0.094)。
  • 医生经验≥3年、牙周炎IV期、非吸烟者等与抗生素处方几率升高相关。
  • 研究样本有限,结果需谨慎解读,微生物检测不应作为常规处方依据。

核心结论

  • 在有限病例和医生中,微生物检测与牙周基础治疗后全身抗生素处方无显著关联,但多个患者和医生相关因素与处方相关。

主要发现

  • 有微生物信息时平均56%(95%CI [0.51; 0.61])的病例处方全身抗生素,无信息时52%(95%CI [0.47; 0.57]),p=0.094。
  • 医生经验≥3年时处方全身抗生素的比值比为3.34(95%CI [2.06; 5.42])。
  • 牙周炎IV期患者相比III期,处方全身抗生素的比值比为2.55(95%CI [1.40; 4.66])。
  • 年轻患者处方全身抗生素的比值比为1.08(95%CI [1.04; 1.11])。
  • 非吸烟者处方全身抗生素的比值比为2.78(95%CI [1.37; 5.56]),需拔除牙少于3颗时比值比为2.22(95%CI [1.27; 3.85])。

关键数值与推荐

  • 检出A.actinomycetemcomitans与处方全身抗生素无显著关联(p=0.287)。
  • 牙周炎分级与处方全身抗生素无显著关联(p=0.499)。
  • 患者性别与处方全身抗生素无显著关联(p=0.067)。

临床怎么用

  • 牙周基础治疗后处方全身抗生素不应仅依赖微生物检测结果,需综合考虑医生经验、牙周炎分期、吸烟状态和需拔牙数等因素。

局限性

  • 研究基于有限数量的病例和临床医生,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: (1) To assess prescription of systemic antibiotics following initial periodontal therapy with and without the availability of microbiological information; (2) To identify factors associated with prescription of systemic antibiotics following initial periodontal therapy. MATERIALS AND METHODS: Twenty-four clinicians were invited to complete a questionnaire on 20 patient records with respect to periodontal treatment planning, once with microbiological information available and once without. Randomization determined when the microbiological information was provided, and a 3-month washout period was respected between scoring sessions. Regression analysis was performed to identify factors associated with prescription of systemic antibiotics. RESULTS: Twenty-one clinicians completed both scoring sessions. Clinicians prescribed systemic antibiotics in on average 56% (95% Confidence Interval (CI) [0.51; 0.61]) of the cases having microbiological information, and in 52% (95% CI [0.47; 0.57]) of the same cases not having that information (p = 0.094). The odds for prescribing systemic antibiotics were 3.34 (95% CI [2.06; 5.42]) times higher when the clinician had at least 3 years of experience, 2.55 (95% CI [1.40; 4.66]) times higher for patients diagnosed with periodontitis stage IV when compared to stage III, 1.08 (95% CI [1.04; 1.11]) times higher for younger patients, 2.78 times (95% CI [1.37; 5.56]) times higher for non-smokers and 2.22 (95% CI [1.27; 3.85]) times higher when less than three teeth would require extraction. No significant associations with the prescription of systemic antibiotics were found for detection of A.actinomycetemcomitans (p = 0.287), grade of periodontitis (p = 0.499) and gender of the patient (p = 0.067). CONCLUSIONS: Based on a limited number of cases and clinicians, several patient and clinician related factors were associated with prescription of systemic antibiotics following initial periodontal therapy. However, microbiological testing was not.

来源:J Clin Periodontol,查看原文。版权归原作者所有。

引用

  1. Vrijghem C, Cosyn J, Fransen J, et al. A questionnaire-based crossover study on the association of microbiological testing with prescription of systemic antibiotics following initial periodontal therapy. J Clin Periodontol. 2021. PMID: 33751614. doi:10.1111/jcpe.13453

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。